|
Caffrey, P B; Frenkel, G D (2000) Selenium compounds prevent the induction of drug resistance by cisplatin in human ovarian tumor xenografts in vivo. Cancer Chemother Pharmacol 46:74-8
|
|
Caffrey, P B; Zhu, M; Zhang, Y et al. (1999) Rapid development of glutathione-S-transferase-dependent drug resistance in vitro and its prevention by ethacrynic acid. Cancer Lett 136:47-52
|
|
Caffrey, P B; Zhang, Y; Frenkel, G D (1998) Rapid development of drug resistance in human ovarian tumor xenografts after a single treatment with melphalan in Vivo. Anticancer Res 18:3021-5
|
|
Zhu, M; Gong, Y; Frenkel, G D (1998) Studies on the mechanism of the selenite-induced decrease in cell attachment: effect of selenite on the levels of fibronectin receptor (alpha5beta1 integrin) mRNAs. Biol Trace Elem Res 62:123-34
|
|
Caffrey, P B; Frenkel, G D (1998) Treatment of human ovarian tumor xenografts with selenite prevents the melphalan-induced development of drug resistance. Anticancer Res 18:3017-20
|
|
Caffrey, P B; Zhu, M; Frenkel, G D (1998) Prevention of the development of melphalan resistance in vitro by selenite. Biol Trace Elem Res 65:187-95
|
|
Caffrey, P B; Frenkel, G D (1997) Sensitivity of melphalan-resistant tumors to selenite in vivo. Cancer Lett 121:177-80
|
|
Yan, L; Frenkel, G D (1994) Protein synthesis is not required for the inhibitory effect of selenite on cell colony formation and RNA synthesis. Biol Trace Elem Res 40:181-7
|
|
Yan, L; Frenkel, G D (1994) Effect of selenite on cell surface fibronectin receptor. Biol Trace Elem Res 46:79-89
|
|
Caffrey, P B; Frenkel, G D (1994) The development of drug resistance by tumor cells in vitro is accompanied by the development of sensitivity to selenite. Cancer Lett 81:59-65
|
Showing the most recent 10 out of 24 publications
